Neurocrine Biosciences NBIX
NASDAQ NBIX
$141.31 -0.69 (-0.49%)
At close: Oct 21, 2026 · 4:00 PM EDT

Neurocrine Biosciences (NBIX) Shares Repurchased (2024 - 2026)

Updated

Analysis

Neurocrine Biosciences (NBIX) Shares Repurchased (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 221.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 9.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 355.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Neurocrine Biosciences 14.29 Bn 9.99 Bn 935.80 Mn 12.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.00 Mn
Mar 31, 2026 54.00 Mn
Jun 30, 2025 17.70 Mn
Mar 31, 2025 150.00 Mn
Dec 31, 2024 300.00 Mn
API Access

Neurocrine Biosciences Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=NBIX&period=max&api_key=YOUR_API_KEY